GeneReach Biotechnology Corp. (TPEX:4171)

GeneReach Biotechnology Revenue

GeneReach Biotechnology had revenue of 52.28M TWD in the quarter ending March 31, 2026, a decrease of -0.36%. This brings the company's revenue in the last twelve months to 232.55M, up 9.15% year-over-year. In the year 2025, GeneReach Biotechnology had annual revenue of 232.74M with 12.71% growth.

• Revenue (ttm): 232.55M
• Revenue Growth: +9.15%
• P/S Ratio: 4.37
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	232.74M	26.25M	12.71%
Dec 31, 2024	206.49M	-18.97M	-8.41%
Dec 31, 2023	225.46M	-524.56M	-69.94%
Dec 31, 2022	750.02M	-262.06M	-25.89%
Dec 31, 2021	1.01B	155.04M	18.09%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error